The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer 5 Feb, 2021 | 01:19h | UTC The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer – JACC: CardioOncology See also: Management of Immune Checkpoint Inhibitor–Induced Myocarditis: The French Working Group’s Plea for a Pragmatic Approach – JACC: CardioOncology Commentary: JACC: CardioOncology Papers Discuss Evolving Landscape of Immune Checkpoint Inhibitors – American College of Cardiology